Epinephrine Bitartrate, Lido · #3 of 35 active shortages by FDA posting duration
Brand: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
FDA lists Epinephrine Bitartrate, Lido as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Unavailable
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: Active Shortage
Unavailable 24 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)
- Package NDC
- 0409-3178-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Feb 22, 2012
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
Full Drug Profile
epinephrine
Side effects, interactions, warnings & more
Nearby, Other Epinephrine Shortage Records
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay. General shortage guidance lives on the tracker hub.